Compare Raymond James Financial, Inc. (RJF) vs Stryker Corporation (SYK) Price & Performance

Raymond James Financial, Inc.Trade

Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Raymond James Financial, Inc. vs Stryker Corporation — how do they compare? Raymond James Financial, Inc. trades at $167 (market cap $32.73B), while Stryker Corporation trades at $309.5 (market cap $120.60B). The key difference: Stryker Corporation is far larger — about 3.7× Raymond James Financial, Inc.'s market cap, and Raymond James Financial, Inc. pays the higher dividend (1.29%). Which is the better fit depends on your goals.

	RJF	SYK
Market Cap	$32.73B	$120.60B
Sector	Financials	Technology
52-Week High	$176.43	$403.53
52-Week Low	$140.89	$282.58
Dividend Yield	1.29%	1.12%
Enterprise Value	—	$132.36B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Raymond James Financial, Inc.

No Aura AI signal available yet.

Stryker Corporation

Stryker (SYK) trades at $319.14, down 0.23% with a bearish technical signal despite strong fundamentals. The company reported $25.12B revenue and $3.25B net income for 2025, maintaining robust margins. Recent news highlights Mako RPS launch expansion in robotic surgery, while Q1 2026 earnings missed expectations due to a temporary cyber disruption, though full-year guidance remains unchanged.

Outlook remains positive with 74% analyst buy ratings and a $388.44 consensus price target implying 22% upside. Key risks include competitive pressures and execution challenges from recent cybersecurity issues. The stock presents a growth opportunity in med-tech innovation, trading below historical valuation multiples with healthy cash flow generation.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RJF

Raymond James reports record Q3 net revenues of $3.93B and net income of $595M, driven by strong asset growth.GlobeNewsWire · 7 hours agoBullish View details →

SYK

Robotic endoscopy devices market to grow at 10% CAGR, reaching $6.5B by 2034 driven by tech advances and rising GI disorders.Delveinsight · 7 hours agoBullish Global indocyanine green market to grow to $380M by 2031, driven by surgical imaging advances.PRNewsWire · 13 hours agoBullish View details →

About Raymond James Financial, Inc.

Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.